Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H OERTEL

Showing results (311-320 of 678) with videos related to

Pageof 68
Sort By:
Neurology|July 1, 1994
[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptorsA Antonini, J Schwarz, W H Oertel, et al.
Veterinary Parasitology|July 13, 2000
Effects of Psoroptes ovis infection and its control with an ivermectin controlled-release capsule on growing sheep. 2. Evaluation of wool production and leather valueS Rehbein, H Oertel, D Barth, et al.
Life Sciences|January 1, 1983
Opioid peptide-like immunoreactivity localized in GABAErgic neurons of rat neostriatum and central amygdaloid nucleusW H Oertel, G Riethmüller, E Mugnaini, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 24, 2006
Modulation of human motor cortex excitability by single doses of amantadineJanine Reis, Daniel John, Antje Heimeroth, et al.
Headache|September 12, 2008
Serum concentrations of s100b and NSE in migraineMichael Teepker, Karoline Munk, Veit Mylius, et al.
European Journal of Neurology|August 22, 2008
Clinical risk-benefit assessment of dopamine agonistsJ C Möller, K M Eggert, M Unger, et al.
Experimental Neurology|August 18, 2009
Natural lipophilic inhibitors of mitochondrial complex I are candidate toxins for sporadic neurodegenerative tau pathologiesMatthias Höllerhage, Andreas Matusch, Pierre Champy, et al.
Neuroscience Letters|November 6, 2012
Neuregulin-1 receptor tyrosine kinase ErbB4 is upregulated in midbrain dopaminergic neurons in Parkinson diseaseCandan Depboylu, Matthias Höllerhage, Stefan Schnurrbusch, et al.
Der Nervenarzt|January 9, 2014
[REM sleep behavior disorder as a prodromal stage of α-synucleinopathies: symptoms, epidemiology, pathophysiology, diagnosis and therapy]W H Oertel, C Depboylu, M Krenzer, et al.
Pharmacoeconomics|August 5, 1998
The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysisR C Dodel, M Singer, R Köhne-Volland, et al.
Pageof 68

Showing results (311-320 of 678) with videos related to

Sort By:
Pageof 68
Neurology|July 1, 1994
[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptorsA Antonini, J Schwarz, W H Oertel, et al.
Veterinary Parasitology|July 13, 2000
Effects of Psoroptes ovis infection and its control with an ivermectin controlled-release capsule on growing sheep. 2. Evaluation of wool production and leather valueS Rehbein, H Oertel, D Barth, et al.
Life Sciences|January 1, 1983
Opioid peptide-like immunoreactivity localized in GABAErgic neurons of rat neostriatum and central amygdaloid nucleusW H Oertel, G Riethmüller, E Mugnaini, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 24, 2006
Modulation of human motor cortex excitability by single doses of amantadineJanine Reis, Daniel John, Antje Heimeroth, et al.
Headache|September 12, 2008
Serum concentrations of s100b and NSE in migraineMichael Teepker, Karoline Munk, Veit Mylius, et al.
European Journal of Neurology|August 22, 2008
Clinical risk-benefit assessment of dopamine agonistsJ C Möller, K M Eggert, M Unger, et al.
Experimental Neurology|August 18, 2009
Natural lipophilic inhibitors of mitochondrial complex I are candidate toxins for sporadic neurodegenerative tau pathologiesMatthias Höllerhage, Andreas Matusch, Pierre Champy, et al.
Neuroscience Letters|November 6, 2012
Neuregulin-1 receptor tyrosine kinase ErbB4 is upregulated in midbrain dopaminergic neurons in Parkinson diseaseCandan Depboylu, Matthias Höllerhage, Stefan Schnurrbusch, et al.
Der Nervenarzt|January 9, 2014
[REM sleep behavior disorder as a prodromal stage of α-synucleinopathies: symptoms, epidemiology, pathophysiology, diagnosis and therapy]W H Oertel, C Depboylu, M Krenzer, et al.
Pharmacoeconomics|August 5, 1998
The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysisR C Dodel, M Singer, R Köhne-Volland, et al.
Pageof 68